Analytica 2020
The International Trade Fair for Laboratory Technology, Analysis, Biotechnology and Analytica Conference 2020 will take place in the International Congress Center (ICM), Munich, Germany, from 31 March to 3 April 2020.
Image Credit: f11photo/stock.adobe.com
The International Trade Fair for Laboratory Technology, Analysis, Biotechnology and Analytica Conference 2020 will take place in the International Congress Center (ICM), Munich, Germany, from 31 March to 3 April 2020.
From doping control to the detection of antibiotic-resistant germs to artificial intelligence (AI) in the laboratory, the Analytica conference reflects the entire spectrum of modern analysis. Attention increasingly rests on digitization in analytical disciplines: What do materials scientists use artificial intelligence methods for? How do physicians handle the increasing flood of data? What digital techniques can be used to optimize the monitoring of industrial processes? These and many other questions are being discussed by renowned researchers from around the world at the Analytica conference.
In addition to the overarching focus on digitalization, the conference agenda covers a wide range of current topics. The subject of doping control will be prominent with the Summer Olympic Games in Tokyo on the horizon. The wide variety of performance-enhancing substances-ranging from small inorganic substances to large biomolecules-are constantly changing and analytical techniques are in a constant race to keep up, making doping an exciting topic to cover.
The basis of the Analytica conference continues to be the numerous new developments in instrumental analysis. Thus, there are dedicated sessions on chromatography and mass spectrometry, spectroscopy, microscopy, and electroanalysis covering recent advancements and what the future holds for those techniques. A further session has been organized jointly by the “Pharmaceutical and Chemical Group” from Merck and the diagnostics company Immundiagnostik and will feature a series of lectures on biotechnologically produced active pharmaceutical ingredients. The importance of analysis for the pharmaceutical and healthcare sector is a major topic of interest at Analytica.
The multifaceted programme, organized by the Association of German Chemists (Gesellschaft Deutscher Chemiker, GDCh), the Society for Biochemistry and Molecular Biology (Gesellschaft für Biochemie und Molekularbiologie, GBM), and the German Society for Clinical Chemistry and Laboratory Medicine (Deutsche Gesellschaft für Klinische Chemie und Laboratoriumsmedizin, DGKL), invites you to look beyond your own horizons and let yourself be inspired by colleagues from other analytical disciplines.
The Analytica conference offers a great opportunity to exchange experience with your peers-and in the age of digitization and digitalization, this is more important than ever. Despite the many digital techniques and extremely helpful methods of AI, the knowledge, inventiveness, and, last but not least, intuition of experienced analysts will remain irreplaceable in the future. The challenge is to combine human expertise with the capabilities of machines. At the Analytica conference in Munich from 31 March to 3 April 2020, visitors can learn how this is already being done today and what opportunities this will open up for the analysis of tomorrow.
The Analytica conference takes place in the ICM in the immediate vicinity of the exhibition halls and is free for all Analytica visitors. For more information, please visit www.analytica.de/conference
New Study Uses MSPE with GC–MS to Analyze PFCAs in Water
January 20th 2025Scientists from the China University of Sciences combined magnetic solid-phase extraction (MSPE) with gas chromatography–mass spectrometry (GC–MS) to analyze perfluoro carboxylic acids (PFCAs) in different water environments.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ion used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.
